Uploaded July 2025 | Updated September 2026, 2 weeks ago
Dr. Mark Scialdone is a recognized expert in the field of organic chemistry, specializing in natural product chemistry, including plant oil extraction, analysis, and chemical modification. He is an inventor of 37 issued US patents and has authored 17 peer-reviewed publications, during more than two decades of fundamental and product development research. He has given numerous invited lectures at more than 40 different academic institutions and international symposia.
At CannMed 25, Mark participated in the Hemp-Derived Cannabinoids panel, which explored the rapid rise of products containing chemically transformed cannabinoids to exploit the 2018 Farm Bill loophole. He also presented a poster that explained the process for chemically converting cannabinoids in more detail.
During our conversation we discussed:
* Why producers and manufacturers would want to convert one cannabinoid into another
* Common methods for cannabinoid conversion
* Safety risks associated with chemical cannabinoid conversion
* The legality of these compounds
* How these compouns and these products are affecting the legal cannabis market
* The therapeutic potential of novel, chemically-converted cannabinoids
* and more
Thanks to This Episode’s Sponsor: Cannabis & Tech Today
Cannabis & Tech Today is the premier publication for the business, science, and innovations shaping the cannabis industry. From exclusive interviews with industry leaders to deep dives on the latest tech, they cover it all.
Go to cannatechtoday.com to subscribe to their digital and print editions and gain access to exclusive interviews, brand-new technology, and thought-provoking articles from every corner of the cannabis community.
Additional Resources
* Pre-Register for CannMed 26 for just $100 (cvent.me/ryXrgZ)
* CannMed Video Archive (cannmedevents.com/cannmed-video-archives/)
* Connect with Mark on LinkedIn (linkedin.com/in/mark-scialdone-0247625b/)
* The Dark Side of Cannabidiol (CBD): The Unanticipated Social and Clinical Implications of Synthetic Δ8-THC (pubmed.ncbi.nlm.nih.gov/36264171/)
* Hash Church on YouTube (youtube.com/playlist?list=PL668WdsJxoe3m1XJPFCBQ2h4JUy8ulCLx)
* CANN Delta-8-THC Panel Discussion (youtu.be/rdbQXLfKREg?si=Rrrk7gKpC4fH2ELJ)
* GC Separation for Identification of iso-THC Contaminants and Accurate Quantification of Δ8 -THC and Δ9-THC in Cannabis Samples (caymanchem.com/literature/GC-Identification-of-iso-THC-Contaminants?srsltid=AfmBOoqiSA7-_N7g0lObACmVbGrCjyY3yrbCscyNkuDBws-o-_4-fId5)
Dr. Mark Scialdone is a recognized expert in the field of organic chemistry, specializing in natural product chemistry, including plant oil extraction, analysis, and chemical modification. He is an inventor of 37 issued US patents and has authored 17 peer-reviewed publications, during more than two decades of fundamental and product development research. He has given numerous invited lectures at more than 40 different academic institutions and international symposia.
At CannMed 25, Mark participated in the Hemp-Derived Cannabinoids panel, which explored the rapid rise of products containing chemically transformed cannabinoids to exploit the 2018 Farm Bill loophole. He also presented a poster that explained the process for chemically converting cannabinoids in more detail.
During our conversation we discussed:
* Why producers and manufacturers would want to convert one cannabinoid into another
* Common methods for cannabinoid conversion
* Safety risks associated with chemical cannabinoid conversion
* The legality of these compounds
* How these compouns and these products are affecting the legal cannabis market
* The therapeutic potential of novel, chemically-converted cannabinoids
* and more
Thanks to This Episode’s Sponsor: Cannabis & Tech Today
Cannabis & Tech Today is the premier publication for the business, science, and innovations shaping the cannabis industry. From exclusive interviews with industry leaders to deep dives on the latest tech, they cover it all.
Go to cannatechtoday.com to subscribe to their digital and print editions and gain access to exclusive interviews, brand-new technology, and thought-provoking articles from every corner of the cannabis community.
Additional Resources
* Pre-Register for CannMed 26 for just $100 (cvent.me/ryXrgZ)
* CannMed Video Archive (cannmedevents.com/cannmed-video-archives/)
* Connect with Mark on LinkedIn (linkedin.com/in/mark-scialdone-0247625b/)
* The Dark Side of Cannabidiol (CBD): The Unanticipated Social and Clinical Implications of Synthetic Δ8-THC (pubmed.ncbi.nlm.nih.gov/36264171/)
* Hash Church on YouTube (youtube.com/playlist?list=PL668WdsJxoe3m1XJPFCBQ2h4JUy8ulCLx)
* CANN Delta-8-THC Panel Discussion (youtu.be/rdbQXLfKREg?si=Rrrk7gKpC4fH2ELJ)
* GC Separation for Identification of iso-THC Contaminants and Accurate Quantification of Δ8 -THC and Δ9-THC in Cannabis Samples (caymanchem.com/literature/GC-Identification-of-iso-THC-Contaminants?srsltid=AfmBOoqiSA7-_N7g0lObACmVbGrCjyY3yrbCscyNkuDBws-o-_4-fId5)









![Demystifying Cannabinoid Hyperemesis Syndrome with Codi Peterson, PharmD
Dr. Codi Peterson is a pediatric pharmacist with over a decade of experience specializing in acute care and pediatric emergency medicine. He currently serves as a clinical pharmacist at Radys Childrens Health of Orange County, where he works night shifts in the Emergency Department and applies his expertise to optimize medication safety and therapeutic outcomes in children. Beyond the hospital, Codi is deeply committed to education and mentorship. He is an Associate Clinical Professor at the University of California, Irvine, where he teaches cannabis pharmacology and therapeutics, and a guest lecturer at OCEMT, instructing paramedics and firefighters in applied pharmacology.
He is also an active researcher on Cannabinoid Hyperemesis Syndrome (CHS), having led one of the largest patient surveys on the condition to date. At CannMed 26, Codi will share the results of that study in a presentation titled, “Through the Eyes of a Patient: Integrating Story and Science to Demystify CHS”.
During our conversation, we discuss:
- Defining CHS and explaining why it is difficult to research
- Cannabis use patterns among CHS sufferers
- Whether contaminants and pesticides play a role in developing CHS
- The prodromal phase and early warning signs of CHS
- Sex-based differences in CHS patients
- Understanding the biological mechanisms behind the development of CHS
- and more
Thanks to This Episodes Sponsor: The Cannigma
The Cannigma takes an evidence-based approach to cannabis content – from safety to cooking to medical research – and makes all the information digestible and useful.
They are committed to making sure scientific information is accessible to anyone who needs it – be it to relieve their own suffering or that of a loved one, to learn a bit more, or even just for fun.
Learn more at cannigma.com
Additional Resources
- Surveying Cannabinoid Hyperemesis Syndrome Patients with Megan Mbengue and Codi Peterson [Video] - https://youtu.be/ez7PyEESrSU
- Cannabinoid Hyperemesis Syndrome What You Need to Know [Video] - https://youtu.be/9hCp6puJvXc?si=Gc14ELLhC3S5KOBL
- what-is-chs.com
- Codi on IG - https://www.instagram.com/cannabispharmd/
- Codi on LinkedIn - https://www.linkedin.com/in/cannapharmd/
- The Cannigma - cannigma.com
- Register for CannMed 26 - Early Bird Ends February 20th! - https://cannmedevents.com/package-options/ Demystifying Cannabinoid Hyperemesis Syndrome with Codi Peterson, PharmD](https://i.ytimg.com/vi/bIZi75xoUyk/mqdefault.jpg)
